NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Northwest Biotherapeutics Inc


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Biologics Consulting Group, Inc. Appoints Michael L. Salgaller, PhD, as President and Chief Operating Officer, and Holly M. Scott as Senior Consultant
2009 AUG 17 ... Biosystems Ltd., Biotechnology, Biotechnology Business, Biotechnology Company, Northwest Biotherapeutics Inc., Biologics Consulting Group Inc. This article was prepared by Biotech ...
Subject: Biologics Consulting Group, Inc.
Price: $3.00
*
Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
2009 NOV 2 ... Cancer Vaccines, Chemotherapy, Clinical Trial Research, Drug Therapy, FDA, Glioblastoma, Northwest Biotherapeutics Inc., Oncology, Surgery, U.S. Food and Drug Administration,...
Subject: Cancer Vaccines
Price: $3.00
*
Mentor Capital Cancer Immunotherapy Index Improves at a 320% Annualized Rate for Quarter
2009 NOV 2 ... Biovest International (PINK SHEETS:BVTI), Celldex Therapeutics (NASDAQ:CLDX), Northwest Biotherapeutics (NWBO.OB), CEL - SCI Corp. (AMEX:CVM), Generex Biotechnology ... during the quarter in both growth and potential growth. ImmunoCellular Therapeutics, Inc. (IMUC.OB) was 1st in growth, and 2nd in remaining potential. Mentor Capital, Inc. (PINK ...
Subject: Mentor Capital, Inc.
Price: $3.00
*
Mentor Capital Cancer Immunotherapy Index Posts Second 20% Plus Monthly Gain Lead by ImmunoCellular Therapeutics
2009 SEP 28 ... Biovest International (PINK SHEETS:BVTI), Celldex Therapeutics (NASDAQ:CLDX), Northwest Biotherapeutics (NWBO.OB), CEL - SCI Corp. (AMEX:CVM), Generex Biotechnology ... Index gain was paced by the 233% share price improvement of ImmunoCellular Theraputics, Inc. (IMUC.OB) under the leadership of CEO Manish Singh, Ph. D. The increased interest in ...
Subject: Mentor Capital, Inc.
Price: $3.00
*
New Cancer Immunotherapy Index Posts 23% Gains Lead by Mentor Capital, Inc. and Oncothyreon
2009 SEP 14 ... (NASDAQ:AGEN), Biovest International (BVTI.PK), Celldex Therapeutics (NASDAQ:CLDX), Northwest Biotherapeutics (NWBO.OB), CEL - SCI Corp. (AMEX:CVM) and Generex Biotechnology ... six-week CI Index gain was paced by the 78% share price improvement of Mentor Capital, Inc. (Pink Sheets: MNTR). On July 10, 2009, Mentor Capital announced it had acquired a ...
Subject: Mentor Capital, Inc.
Price: $3.00
*
Northwest Biotherapeutics Reports Encouraging Data on First Patients Who Have Completed Its Phase I/II Clinical Trial of DCVax(R)-L in Metastatic Ovarian Cancer
2009 JAN 5 ... Inhibitor, Gastroenterology, Gemcitabine, Gynecology, Immunization, Immunosuppressant, Northwest Biotherapeutics Inc., Oncology, Ovarian Cancer, Ovarian Carcinoma, Paclitaxel, Pharmaceuticals, ...
Subject: Cancer Vaccines
Price: $3.00
*
Northwest Biotherapeutics Secures $700,000 Equity Financing
2009 FEB 23 ... Biopharmaceuticals, Biotechnology, Biotechnology Business, Biotechnology Company, Northwest Biotherapeutics Inc., Northwest Biotherapeutics Inc. This ...
Subject: Bioengineering
Price: $3.00
*
Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action
2009 JAN 19 ... Biopharmaceuticals, Biotechnology, Biotechnology Business, Biotechnology Company, Northwest Biotherapeutics Inc., Northwest Biotherapeutics Inc. This ...
Subject: Bioengineering
Price: $3.00
*
Study data from C.J. Wheeler and co-authors update knowledge of immunization
2009 JUN 29 ... Cancer, Brain Carcinoma, Cancer Vaccines, Glioblastoma, Immunization, Immunotherapy, Northwest Biotherapeutics Inc., Oncology, Treatment, Vaccination, Vaccine Efficacy. This article was ...
Subject: Immunization
Price: $3.00
*
Tatum Expands Mid-Atlantic Practice
2009 JAN 26 ... segments. Prior to joining Tatum, Deasey served as Senior VP, Finance and CFO at Northwest Biotherapeutics Inc. where he was instrumental in establishing a subsidiary and recruiting staff to manage a ...
Subject: Tatum LLC
Price: $3.00
*
Michael L. Salgaller, Ph.D., Appointed Chief Operating Officer of Calibrant Biosystems
2008 FEB 4 ... Prior to Toucan Dr. Salgaller was Vice President of Clinical and Research Affairs at Northwest Biotherapeutics, a publicly held cancer therapeutics company, where he lead the ...
Subject: Cancer Vaccines
Price: $3.00
*
Northwest Biotherapeutics to Present at Next Generation Vaccine Conference
2008 JUL 28 ... Business, Biotechnology Company, Cancer Vaccines, Glioblastoma, Hormones, Immunization, Northwest Biotherapeutics Inc., Oncology, Prostate Cancer, Prostatic Neoplasms, Therapy, Treatment, Vaccination. ...
Subject: Northwest Biotherapeutics
Price: $3.00
*
Northwest Secures US$1.0 Million Debt Financing
2008 OCT 13 ... Keywords: Northwest Biotherapeutics, Inc., Biopharmaceuticals, Biotechnology, Northwest Biotherapeutics Inc., Biotechnology Business, Biotechnology Company This article was prepared ...
Subject: Northwest Biotherapeutics, Inc.
Price: $3.00
*
Northwest Secures US$1.65 Million Debt Financing
2008 NOV 17 ... Keywords: Northwest Biotherapeutics, Inc., Biopharmaceuticals, Biotechnology, Northwest Biotherapeutics Inc., Biotechnology Business, Biotechnology Company This article was prepared ...
Subject: Northwest Biotherapeutics, Inc.
Price: $3.00
*
Northwest Secures US$4.0 Million in Debt Financing
2008 MAY 26 ... Keywords: Northwest Biotherapeutics, Inc., Biopharmaceuticals, Biotechnology, Northwest Biotherapeutics Inc., Biotechnology Business, Biotechnology Company This article was prepared ...
Subject: Northwest Biotherapeutics, Inc.
Price: $3.00
*
Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
2008 MAR 3 ... Company, Brain Cancer, Brain Carcinoma, Clinical Trial Research, Glioblastoma, Northwest Biotherapeutics Inc., Oncology, Northwest Biotherapeutics Inc. ...
Subject: Brain Cancer
Price: $3.00
*
Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
2008 SEP 1 ... Dr. Stromatt was vice president of clinical research and chief medical officer at Northwest Biotherapeutics Inc. in Bothell, Wash. "Dr. Stromatt's experience, particularly in the area ...
Subject: Biotechnology Business
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login